A team of Barcelona-based researchers developed an algorithm that exhibits high accuracy in predicting the dignity of mediastinal and hilar lymph nodes in lung cancer patients .
Classically, PET-CT scans and EBUS-TBA (endobronchial ultrasound-guided transbronchial needle aspiration) are used to determine whether lymph nodes of lung cancer patients found in mediastinum or at the hilum are malignant or not . The retrospective investigation, presented by Jaume Bordad-Martínez (Bellvitge Universitary Hospital, Catalonia, Spain), combined the information provided by the 2 techniques with a list of clinical criteria to develop a model to predict malignancy with high probability. Standardised uptake values (SUV) were determined for each of the 358 lymph node samples obtained from 116 consecutive patients.
Data gathered from the EBUS consisted of diameter in short axis, borders, morphology, echogenicity, and whether a vascular hilum was detected. Also...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« Female COPD Patients Frequently Suffer from Anxiety and Depression Next Article
One Blood Eosinophil Count Is Sufficient to Guide ICS Therapy »
Table of Contents: ERS 2019
Holistic View on Asthma
Infectious Respiratory Disease: the Role of Vaccines
Interstitial Lung Disease
Best of the Posters
Novel Developments in Infectious Disease
A New Trial in Pulmonary Vascular Disease
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.